Uğur Şahin, BioNTech CEO (Photo by: Andreas Arnold/picture-alliance/dpa/AP Images)
BioNTech delves into ADCs with $170M upfront weeks after Pfizer lines up Seagen
As its Covid vaccine partner Pfizer goes all in on the hot field of antibody-drug conjugates, BioNTech will enter the space as well in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
